Basics |
Company: |
Cel-Sci Corporation |
IPO Date: |
December 1, 1984 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$44.66M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.19 | 4.86%
|
Avg Daily Range (30 D): |
$0.05 | 7.62%
|
Avg Daily Range (90 D): |
$0.04 | 4.79%
|
Institutional Daily Volume |
Avg Daily Volume: |
.23M |
Avg Daily Volume (30 D): |
1.3M |
Avg Daily Volume (90 D): |
.64M |
Trade Size |
Avg Trade Size (Sh.): |
134 |
Avg Trade Size (Sh.) (30 D): |
542 |
Avg Trade Size (Sh.) (90 D): |
481 |
Institutional Trades |
Total Inst.Trades: |
350 |
Avg Inst. Trade: |
$1.45M |
Avg Inst. Trade (30 D): |
$.69M |
Avg Inst. Trade (90 D): |
$.69M |
Avg Inst. Trade Volume: |
.12M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.6M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
148.4K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
|
|
|
Diluted EPS
|
$-.51
|
|
$-.51
|
Revenue
|
$ M
|
$ .57M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -26.92M
|
$ -47.73M
|
$ -26.92M
|
Operating Income / Loss
|
$ -26.35M
|
$ -6.12M
|
$ -26.35M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ .59M
|
$ 4.35M
|
$ .59M
|
PE Ratio
|
|
|
|
Splits |
Jun 15, 2017:
25:1
|
Sep 25, 2013:
10:1
|
|